About

What Formulary Insights delivers like no one else is the most complete payer perspective on clinical evidence, whether that be the technical specifications of drug labels or the merit of clinical studies. This is the perspective that will determine how payers view your pricing, and, in turn, the access level granted to your product relative to your competitors.  Other sources simply cannot match the quality or the volume of our active P&T participants—often the difference between a good theory and a firm conclusion.  

Our approach also eliminates the biases that are introduced in live ad boards and phone interviews, so that the insights gained are from the true perspective of the formulary decision maker.  And our Panel includes all payer true perspective of the formulary decision maker.  And our Panel includes all payer types: Insurers, PBMs and Hospital Systems across the US.